2023-2029 Global Rosacea Medications Industry Research & Trends Analysis Report

Publication Month: Mar 2023 | No. of Pages: 165 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Rosacea Medications should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Rosacea Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Rosacea Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Antibiotic segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Rosacea Medications include Lupin Ltd, Dr. Reddy's Laboratories Ltd, VIATRIS (Mylan N.V.), Ajanta Pharma Ltd, Cipla Ltd, Gary Pharmaceuticals P Limited, Glenmark Pharmaceuticals, Teva Pharmaceutical Industries Ltd. and Mission Pharmacal, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Rosacea Medications. Report Highlights:
(1) Global Rosacea Medications market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Rosacea Medications market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Rosacea Medications market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Rosacea Medications segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Rosacea Medications segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Rosacea Medications, capacity, production and trends.
(7) Rosacea Medications industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Antibiotic
Immunosuppressants
Corticosteroids
Others
Market segment by application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Lupin Ltd
Dr. Reddy's Laboratories Ltd
VIATRIS (Mylan N.V.)
Ajanta Pharma Ltd
Cipla Ltd
Gary Pharmaceuticals P Limited
Glenmark Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Mission Pharmacal
Sanofi SA
VYNE Therapeutics
Galderma
Bayer AG
Bausch Health Companies Inc.
Hovione
PruGen Pharmaceuticals
AbbVie, Inc.
Eckson Labs
Sandoz Spa
Abigail Care Pharmaceutical
Pfizer Inc.
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)

1 Market Overview
1.1 Rosacea Medications Definition
1.2 Global Rosacea Medications Market Size and Forecast
1.2.1 By Revenue, Global Rosacea Medications Market Size, 2018-2029
1.2.2 By Sales Volume, Global Rosacea Medications Market Size, 2018-2029
1.2.3 Global Rosacea Medications Price Trend, 2018-2029
1.3 China Rosacea Medications Market Size and Forecast
1.3.1 By Revenue, China Rosacea Medications Market Size, 2018-2029
1.3.2 By Sales Volume, China Rosacea Medications Market Size, 2018-2029
1.3.3 China Rosacea Medications Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Rosacea Medications Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Rosacea Medications Share in Global Market, 2018-2029
1.4.3 Rosacea Medications Market Size: China VS Global, 2018-2029
1.5 Rosacea Medications Market Dynamics
1.5.1 Rosacea Medications Market Drivers
1.5.2 Rosacea Medications Market Restraints
1.5.3 Rosacea Medications Industry Trends
1.5.4 Rosacea Medications Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Rosacea Medications Revenue by Company, 2018-2023
2.2 Global Rosacea Medications Sales Volume by Company, 2018-2023
2.3 Global Rosacea Medications Price by Company, 2018-2023
2.4 Global Rosacea Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Rosacea Medications Concentration Ratio
2.6 Global Rosacea Medications Mergers & Acquisitions, Expansion Plans
2.7 Global Rosacea Medications Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Rosacea Medications Revenue by Company, 2018-2023
3.2 China Rosacea Medications Sales Volume by Company, 2018-2023
3.3 China Rosacea Medications Rosacea Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Rosacea Medications Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Rosacea Medications Domestic VS Export
3.6 China Market, Rosacea Medications Import & Export
3.6.1 China Market, Rosacea Medications Import & Export, 2018-2029
3.6.2 China Rosacea Medications Import & Export Trends
3.6.3 Main Sources of China Rosacea Medications Import
3.6.4 Export Destination of China Rosacea Medications
4 Rosacea Medications Production by Region
4.1 Global Rosacea Medications Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Rosacea Medications Manufacturers
4.3 Global Major Manufacturers, Rosacea Medications Capacity Expansion and Future Plans
4.4 Global Rosacea Medications Capacity by Region
4.5 Global Rosacea Medications Production by Region
4.5.1 Global Rosacea Medications Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Rosacea Medications Production by Region, 2018-2023
4.5.3 Global Rosacea Medications Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Rosacea Medications Industry Chain
5.2 Rosacea Medications Upstream Analysis
5.2.1 Rosacea Medications Core Raw Materials
5.2.2 Main Manufacturers of Rosacea Medications Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Rosacea Medications Production Mode
5.6 Rosacea Medications Procurement Model
5.7 Rosacea Medications Industry Sales Model and Sales Channels
5.7.1 Rosacea Medications Sales Model
5.7.2 Rosacea Medications Typical Distributors
6 Sights by Type
6.1 Rosacea Medications Classification
6.1.1 Antibiotic
6.1.2 Immunosuppressants
6.1.3 Corticosteroids
6.1.4 Others
6.2 By Type, Global Rosacea Medications Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Rosacea Medications Revenue, 2018-2029
6.4 By Type, Global Rosacea Medications Sales Volume, 2018-2029
6.5 By Type, Global Rosacea Medications Price, 2018-2029
7 Sights by Application
7.1 Rosacea Medications Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Others
7.2 By Application, Global Rosacea Medications Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Rosacea Medications Revenue, 2018-2029
7.4 By Application, Global Rosacea Medications Sales Volume, 2018-2029
7.5 By Application, Global Rosacea Medications Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Rosacea Medications Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Rosacea Medications Revenue, 2018-2029
8.3 By Region, Global Rosacea Medications Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Rosacea Medications Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Rosacea Medications Market Size Market Share
8.5 Europe
8.5.1 Europe Rosacea Medications Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Rosacea Medications Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Rosacea Medications Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Rosacea Medications Market Size Market Share
8.7 South America
8.7.1 South America Rosacea Medications Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Rosacea Medications Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Rosacea Medications Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Rosacea Medications Revenue, 2018-2029
9.3 By Country, Global Rosacea Medications Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Rosacea Medications Market Size, 2018-2029
9.4.2 By Company, U.S. Rosacea Medications Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Rosacea Medications Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Rosacea Medications Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Rosacea Medications Market Size, 2018-2029
9.5.2 By Company, Europe Rosacea Medications Sales Volume Market Share, 2022
9.5.3 By Type, Europe Rosacea Medications Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Rosacea Medications Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Rosacea Medications Market Size, 2018-2029
9.6.2 By Company, China Rosacea Medications Sales Volume Market Share, 2022
9.6.3 By Type, China Rosacea Medications Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Rosacea Medications Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Rosacea Medications Market Size, 2018-2029
9.7.2 By Company, Japan Rosacea Medications Sales Volume Market Share, 2022
9.7.3 By Type, Japan Rosacea Medications Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Rosacea Medications Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Rosacea Medications Market Size, 2018-2029
9.8.2 By Company, South Korea Rosacea Medications Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Rosacea Medications Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Rosacea Medications Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Rosacea Medications Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Rosacea Medications Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Rosacea Medications Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Rosacea Medications Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Rosacea Medications Market Size, 2018-2029
9.10.2 By Company, India Rosacea Medications Sales Volume Market Share, 2022
9.10.3 By Type, India Rosacea Medications Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Rosacea Medications Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Rosacea Medications Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Rosacea Medications Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Rosacea Medications Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Rosacea Medications Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Lupin Ltd
10.1.1 Lupin Ltd Company Information, Head Office, Market Area and Industry Position
10.1.2 Lupin Ltd Rosacea Medications Models, Specifications and Application
10.1.3 Lupin Ltd Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Lupin Ltd Company Profile and Main Business
10.1.5 Lupin Ltd Recent Developments
10.2 Dr. Reddy's Laboratories Ltd
10.2.1 Dr. Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
10.2.2 Dr. Reddy's Laboratories Ltd Rosacea Medications Models, Specifications and Application
10.2.3 Dr. Reddy's Laboratories Ltd Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Dr. Reddy's Laboratories Ltd Company Profile and Main Business
10.2.5 Dr. Reddy's Laboratories Ltd Recent Developments
10.3 VIATRIS (Mylan N.V.)
10.3.1 VIATRIS (Mylan N.V.) Company Information, Head Office, Market Area and Industry Position
10.3.2 VIATRIS (Mylan N.V.) Rosacea Medications Models, Specifications and Application
10.3.3 VIATRIS (Mylan N.V.) Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 VIATRIS (Mylan N.V.) Company Profile and Main Business
10.3.5 VIATRIS (Mylan N.V.) Recent Developments
10.4 Ajanta Pharma Ltd
10.4.1 Ajanta Pharma Ltd Company Information, Head Office, Market Area and Industry Position
10.4.2 Ajanta Pharma Ltd Rosacea Medications Models, Specifications and Application
10.4.3 Ajanta Pharma Ltd Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Ajanta Pharma Ltd Company Profile and Main Business
10.4.5 Ajanta Pharma Ltd Recent Developments
10.5 Cipla Ltd
10.5.1 Cipla Ltd Company Information, Head Office, Market Area and Industry Position
10.5.2 Cipla Ltd Rosacea Medications Models, Specifications and Application
10.5.3 Cipla Ltd Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Cipla Ltd Company Profile and Main Business
10.5.5 Cipla Ltd Recent Developments
10.6 Gary Pharmaceuticals P Limited
10.6.1 Gary Pharmaceuticals P Limited Company Information, Head Office, Market Area and Industry Position
10.6.2 Gary Pharmaceuticals P Limited Rosacea Medications Models, Specifications and Application
10.6.3 Gary Pharmaceuticals P Limited Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Gary Pharmaceuticals P Limited Company Profile and Main Business
10.6.5 Gary Pharmaceuticals P Limited Recent Developments
10.7 Glenmark Pharmaceuticals
10.7.1 Glenmark Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.7.2 Glenmark Pharmaceuticals Rosacea Medications Models, Specifications and Application
10.7.3 Glenmark Pharmaceuticals Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Glenmark Pharmaceuticals Company Profile and Main Business
10.7.5 Glenmark Pharmaceuticals Recent Developments
10.8 Teva Pharmaceutical Industries Ltd.
10.8.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
10.8.2 Teva Pharmaceutical Industries Ltd. Rosacea Medications Models, Specifications and Application
10.8.3 Teva Pharmaceutical Industries Ltd. Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
10.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.9 Mission Pharmacal
10.9.1 Mission Pharmacal Company Information, Head Office, Market Area and Industry Position
10.9.2 Mission Pharmacal Rosacea Medications Models, Specifications and Application
10.9.3 Mission Pharmacal Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Mission Pharmacal Company Profile and Main Business
10.9.5 Mission Pharmacal Recent Developments
10.10 Sanofi SA
10.10.1 Sanofi SA Company Information, Head Office, Market Area and Industry Position
10.10.2 Sanofi SA Rosacea Medications Models, Specifications and Application
10.10.3 Sanofi SA Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Sanofi SA Company Profile and Main Business
10.10.5 Sanofi SA Recent Developments
10.11 VYNE Therapeutics
10.11.1 VYNE Therapeutics Company Information, Head Office, Market Area and Industry Position
10.11.2 VYNE Therapeutics Rosacea Medications Models, Specifications and Application
10.11.3 VYNE Therapeutics Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 VYNE Therapeutics Company Profile and Main Business
10.11.5 VYNE Therapeutics Recent Developments
10.12 Galderma
10.12.1 Galderma Company Information, Head Office, Market Area and Industry Position
10.12.2 Galderma Rosacea Medications Models, Specifications and Application
10.12.3 Galderma Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Galderma Company Profile and Main Business
10.12.5 Galderma Recent Developments
10.13 Bayer AG
10.13.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.13.2 Bayer AG Rosacea Medications Models, Specifications and Application
10.13.3 Bayer AG Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Bayer AG Company Profile and Main Business
10.13.5 Bayer AG Recent Developments
10.14 Bausch Health Companies Inc.
10.14.1 Bausch Health Companies Inc. Company Information, Head Office, Market Area and Industry Position
10.14.2 Bausch Health Companies Inc. Rosacea Medications Models, Specifications and Application
10.14.3 Bausch Health Companies Inc. Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Bausch Health Companies Inc. Company Profile and Main Business
10.14.5 Bausch Health Companies Inc. Recent Developments
10.15 Hovione
10.15.1 Hovione Company Information, Head Office, Market Area and Industry Position
10.15.2 Hovione Rosacea Medications Models, Specifications and Application
10.15.3 Hovione Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Hovione Company Profile and Main Business
10.15.5 Hovione Recent Developments
10.16 PruGen Pharmaceuticals
10.16.1 PruGen Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.16.2 PruGen Pharmaceuticals Rosacea Medications Models, Specifications and Application
10.16.3 PruGen Pharmaceuticals Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 PruGen Pharmaceuticals Company Profile and Main Business
10.16.5 PruGen Pharmaceuticals Recent Developments
10.17 AbbVie, Inc.
10.17.1 AbbVie, Inc. Company Information, Head Office, Market Area and Industry Position
10.17.2 AbbVie, Inc. Rosacea Medications Models, Specifications and Application
10.17.3 AbbVie, Inc. Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 AbbVie, Inc. Company Profile and Main Business
10.17.5 AbbVie, Inc. Recent Developments
10.18 Eckson Labs
10.18.1 Eckson Labs Company Information, Head Office, Market Area and Industry Position
10.18.2 Eckson Labs Rosacea Medications Models, Specifications and Application
10.18.3 Eckson Labs Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Eckson Labs Company Profile and Main Business
10.18.5 Eckson Labs Recent Developments
10.19 Sandoz Spa
10.19.1 Sandoz Spa Company Information, Head Office, Market Area and Industry Position
10.19.2 Sandoz Spa Rosacea Medications Models, Specifications and Application
10.19.3 Sandoz Spa Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Sandoz Spa Company Profile and Main Business
10.19.5 Sandoz Spa Recent Developments
10.20 Abigail Care Pharmaceutical
10.20.1 Abigail Care Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.20.2 Abigail Care Pharmaceutical Rosacea Medications Models, Specifications and Application
10.20.3 Abigail Care Pharmaceutical Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Abigail Care Pharmaceutical Company Profile and Main Business
10.20.5 Abigail Care Pharmaceutical Recent Developments
10.21 Pfizer Inc.
10.21.1 Pfizer Inc. Company Information, Head Office, Market Area and Industry Position
10.21.2 Pfizer Inc. Rosacea Medications Models, Specifications and Application
10.21.3 Pfizer Inc. Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.21.4 Pfizer Inc. Company Profile and Main Business
10.21.5 Pfizer Inc. Recent Developments
10.22 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
10.22.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information, Head Office, Market Area and Industry Position
10.22.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Rosacea Medications Models, Specifications and Application
10.22.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Rosacea Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.22.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Profile and Main Business
10.22.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

Tables and Figures

Table 1. Rosacea Medications Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Rosacea Medications Market Restraints
Table 3. Rosacea Medications Market Trends
Table 4. Rosacea Medications Industry Policy
Table 5. Global Rosacea Medications Revenue by Company, 2018-2023, US$ million
Table 6. Global Rosacea Medications Revenue Market Share by Company, 2018-2023
Table 7. Global Rosacea Medications Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Rosacea Medications Sales Volume Market Share by Company, 2018-2023
Table 9. Global Rosacea Medications Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Rosacea Medications Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Rosacea Medications Mergers & Acquisitions, Expansion Plans
Table 12. Global Rosacea Medications Manufacturers Product Type
Table 13. China Rosacea Medications Revenue by Company, 2018-2023, US$ million
Table 14. China Rosacea Medications Revenue Market Share by Company, 2018-2023
Table 15. China Rosacea Medications Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Rosacea Medications Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Rosacea Medications Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Rosacea Medications Import & Export Trends
Table 19. Main Sources of China Rosacea Medications Import
Table 20. Export Destination of China Rosacea Medications
Table 21. Global Headquarters and Manufacturing Base of Rosacea Medications Manufacturers
Table 22. Global Major Manufacturers, Rosacea Medications Capacity Expansion and Future Plans
Table 23. Global Rosacea Medications Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Rosacea Medications Production by Region, 2018-2023, (K Units)
Table 25. Global Rosacea Medications Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Rosacea Medications Upstream (Raw Materials)
Table 27. Global Rosacea Medications Typical Customers
Table 28. Rosacea Medications Typical Distributors
Table 29. By Type, Global Rosacea Medications Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Rosacea Medications Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Rosacea Medications Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Rosacea Medications Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Rosacea Medications Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Rosacea Medications Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Rosacea Medications Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Rosacea Medications Revenue Market Share, 2018-2029
Table 37. By Country, Global Rosacea Medications Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Rosacea Medications Sales Volume Market Share, 2018-2029
Table 39. Lupin Ltd Company Information, Head Office, Market Area and Industry Position
Table 40. Lupin Ltd Rosacea Medications Models, Specifications and Application
Table 41. Lupin Ltd Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Lupin Ltd Company Profile and Main Business
Table 43. Lupin Ltd Recent Developments
Table 44. Dr. Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position
Table 45. Dr. Reddy's Laboratories Ltd Rosacea Medications Models, Specifications and Application
Table 46. Dr. Reddy's Laboratories Ltd Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Dr. Reddy's Laboratories Ltd Company Profile and Main Business
Table 48. Dr. Reddy's Laboratories Ltd Recent Developments
Table 49. VIATRIS (Mylan N.V.) Company Information, Head Office, Market Area and Industry Position
Table 50. VIATRIS (Mylan N.V.) Rosacea Medications Models, Specifications and Application
Table 51. VIATRIS (Mylan N.V.) Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. VIATRIS (Mylan N.V.) Company Profile and Main Business
Table 53. VIATRIS (Mylan N.V.) Recent Developments
Table 54. Ajanta Pharma Ltd Company Information, Head Office, Market Area and Industry Position
Table 55. Ajanta Pharma Ltd Rosacea Medications Models, Specifications and Application
Table 56. Ajanta Pharma Ltd Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Ajanta Pharma Ltd Company Profile and Main Business
Table 58. Ajanta Pharma Ltd Recent Developments
Table 59. Cipla Ltd Company Information, Head Office, Market Area and Industry Position
Table 60. Cipla Ltd Rosacea Medications Models, Specifications and Application
Table 61. Cipla Ltd Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Cipla Ltd Company Profile and Main Business
Table 63. Cipla Ltd Recent Developments
Table 64. Gary Pharmaceuticals P Limited Company Information, Head Office, Market Area and Industry Position
Table 65. Gary Pharmaceuticals P Limited Rosacea Medications Models, Specifications and Application
Table 66. Gary Pharmaceuticals P Limited Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Gary Pharmaceuticals P Limited Company Profile and Main Business
Table 68. Gary Pharmaceuticals P Limited Recent Developments
Table 69. Glenmark Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 70. Glenmark Pharmaceuticals Rosacea Medications Models, Specifications and Application
Table 71. Glenmark Pharmaceuticals Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Glenmark Pharmaceuticals Company Profile and Main Business
Table 73. Glenmark Pharmaceuticals Recent Developments
Table 74. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
Table 75. Teva Pharmaceutical Industries Ltd. Rosacea Medications Models, Specifications and Application
Table 76. Teva Pharmaceutical Industries Ltd. Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
Table 78. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 79. Mission Pharmacal Company Information, Head Office, Market Area and Industry Position
Table 80. Mission Pharmacal Rosacea Medications Models, Specifications and Application
Table 81. Mission Pharmacal Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Mission Pharmacal Company Profile and Main Business
Table 83. Mission Pharmacal Recent Developments
Table 84. Sanofi SA Company Information, Head Office, Market Area and Industry Position
Table 85. Sanofi SA Rosacea Medications Models, Specifications and Application
Table 86. Sanofi SA Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Sanofi SA Company Profile and Main Business
Table 88. Sanofi SA Recent Developments
Table 89. VYNE Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 90. VYNE Therapeutics Rosacea Medications Models, Specifications and Application
Table 91. VYNE Therapeutics Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. VYNE Therapeutics Company Profile and Main Business
Table 93. VYNE Therapeutics Recent Developments
Table 94. Galderma Company Information, Head Office, Market Area and Industry Position
Table 95. Galderma Rosacea Medications Models, Specifications and Application
Table 96. Galderma Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Galderma Company Profile and Main Business
Table 98. Galderma Recent Developments
Table 99. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 100. Bayer AG Rosacea Medications Models, Specifications and Application
Table 101. Bayer AG Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Bayer AG Company Profile and Main Business
Table 103. Bayer AG Recent Developments
Table 104. Bausch Health Companies Inc. Company Information, Head Office, Market Area and Industry Position
Table 105. Bausch Health Companies Inc. Rosacea Medications Models, Specifications and Application
Table 106. Bausch Health Companies Inc. Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Bausch Health Companies Inc. Company Profile and Main Business
Table 108. Bausch Health Companies Inc. Recent Developments
Table 109. Hovione Company Information, Head Office, Market Area and Industry Position
Table 110. Hovione Rosacea Medications Models, Specifications and Application
Table 111. Hovione Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Hovione Company Profile and Main Business
Table 113. Hovione Recent Developments
Table 114. PruGen Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 115. PruGen Pharmaceuticals Rosacea Medications Models, Specifications and Application
Table 116. PruGen Pharmaceuticals Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. PruGen Pharmaceuticals Company Profile and Main Business
Table 118. PruGen Pharmaceuticals Recent Developments
Table 119. AbbVie, Inc. Company Information, Head Office, Market Area and Industry Position
Table 120. AbbVie, Inc. Rosacea Medications Models, Specifications and Application
Table 121. AbbVie, Inc. Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. AbbVie, Inc. Company Profile and Main Business
Table 123. AbbVie, Inc. Recent Developments
Table 124. Eckson Labs Company Information, Head Office, Market Area and Industry Position
Table 125. Eckson Labs Rosacea Medications Models, Specifications and Application
Table 126. Eckson Labs Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Eckson Labs Company Profile and Main Business
Table 128. Eckson Labs Recent Developments
Table 129. Sandoz Spa Company Information, Head Office, Market Area and Industry Position
Table 130. Sandoz Spa Rosacea Medications Models, Specifications and Application
Table 131. Sandoz Spa Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Sandoz Spa Company Profile and Main Business
Table 133. Sandoz Spa Recent Developments
Table 134. Abigail Care Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 135. Abigail Care Pharmaceutical Rosacea Medications Models, Specifications and Application
Table 136. Abigail Care Pharmaceutical Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 137. Abigail Care Pharmaceutical Company Profile and Main Business
Table 138. Abigail Care Pharmaceutical Recent Developments
Table 139. Pfizer Inc. Company Information, Head Office, Market Area and Industry Position
Table 140. Pfizer Inc. Rosacea Medications Models, Specifications and Application
Table 141. Pfizer Inc. Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 142. Pfizer Inc. Company Profile and Main Business
Table 143. Pfizer Inc. Recent Developments
Table 144. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information, Head Office, Market Area and Industry Position
Table 145. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Rosacea Medications Models, Specifications and Application
Table 146. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Rosacea Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 147. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Profile and Main Business
Table 148. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments
List of Figure
Figure 1. Rosacea Medications Picture
Figure 2. By Revenue, Global Rosacea Medications Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Rosacea Medications Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Rosacea Medications Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Rosacea Medications Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Rosacea Medications Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Rosacea Medications Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Rosacea Medications Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Rosacea Medications Share of Global Market, 2018-2029
Figure 10. Global Rosacea Medications Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Rosacea Medications Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Rosacea Medications Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Rosacea Medications Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Rosacea Medications Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Rosacea Medications Domestic VS Export, 2022
Figure 16. Global Rosacea Medications Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Rosacea Medications Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Rosacea Medications Production Market Share & Forecast by Region, 2018-2029
Figure 19. Rosacea Medications Industry Chain
Figure 20. Rosacea Medications Procurement Model
Figure 21. Rosacea Medications Sales Model
Figure 22. Rosacea Medications Sales Channels, Direct Sales and Distribution
Figure 23. Antibiotic
Figure 24. Immunosuppressants
Figure 25. Corticosteroids
Figure 26. Others
Figure 27. By Type, Global Rosacea Medications Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Rosacea Medications Revenue Market Share, 2018-2029
Figure 29. By Type, Global Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Rosacea Medications Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Rosacea Medications Price, 2018-2029, (US$/Unit)
Figure 32. Hospital
Figure 33. Clinic
Figure 34. Others
Figure 35. By Application, Global Rosacea Medications Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Rosacea Medications Revenue Market Share, 2018-2029
Figure 37. By Application, Global Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Rosacea Medications Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Rosacea Medications Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Rosacea Medications Revenue Market Share, 2018-2029
Figure 41. By Region, Global Rosacea Medications Sales Volume Market Share, 2018-2029
Figure 42. North America Rosacea Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Rosacea Medications Revenue Market Share, 2022
Figure 44. Europe Rosacea Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Rosacea Medications Revenue Market Share, 2022
Figure 46. Asia Pacific Rosacea Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Rosacea Medications Revenue Market Share, 2022
Figure 48. South America Rosacea Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Rosacea Medications Revenue Market Share, 2022
Figure 50. Middle East & Africa Rosacea Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Rosacea Medications Market Share, 2022
Figure 53. By Type, U.S. Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Rosacea Medications Market Share, 2022
Figure 57. By Type, Europe Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 59. China Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Rosacea Medications Market Share, 2022
Figure 61. By Type, China Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Rosacea Medications Market Share, 2022
Figure 65. By Type, Japan Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Rosacea Medications Market Share, 2022
Figure 69. By Type, South Korea Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, South Korea Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 71. Southeast Asia Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, Southeast Asia Rosacea Medications Market Share, 2022
Figure 73. By Type, Southeast Asia Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, Southeast Asia Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 75. India Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, India Rosacea Medications Market Share, 2022
Figure 77. By Type, India Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, India Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 79. Middle East & Asia Rosacea Medications Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, Middle East & Asia Rosacea Medications Market Share, 2022
Figure 81. By Type, Middle East & Asia Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, Middle East & Asia Rosacea Medications Sales Volume Market Share, 2022 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets